Optimal Long-Acting Injectable Antipsychotic Management During COVID-19.

Optimal Long-Acting Injectable Antipsychotic Management During COVID-19. J Clin Psychiatry. 2021 Jan 12;82(1): Authors: MacLaurin SA, Mulligan C, Van Alphen MU, Freudenreich O PMID: 33434959 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/33434959?dopt=Abstract

Source: Journal of Clinical Psychiatry - January 14, 2021 Category: Psychiatry Tags: J Clin Psychiatry Source Type: research

More News: COVID-19 | Psychiatry